Georgia ‘Right to Try’ Bill Would Nullify Some FDA Rules, Help Terminally Ill
A bill prefiled in Georgia this week would effectively nullify some Food and Drug Administration (FDA) rules that prevent treatments from being used by terminally-ill patients.
House Bill 34 (HB34), the Right to Try Act, authored by Rep. Mike Dudgeon (R-Johns Creek), is the latest pushback against the FDA and their controversial methodology of approving drugs for mass consumption.
Under HB34, a patient is eligible for experimental drugs or procedures not yet approved by federal regulators if they suffer from “an advanced illness,” have “considered all other treatment options currently approved by the federal Food and Drug Administration,” have been “denied opportunity to participate in a clinical trial,” and possess a “prescription or recommendation by the physician.” The patient is also required to give “written informed consent for the use of the investigational drug, biological product, or device” or have their legal guardian do so if they are under the age of 18.
Physicians who prescribe these drugs and procedures to patients are shielded from liability under HB34. The bill states that “the Georgia Composite Medical Board shall not revoke, suspend, sanction, fail to renew, or take any other action against a physician’s license solely based on such physician’s recommendation, prescription, or treatment of an eligible patient with an investigational drug, biological product, or device pursuant to this chapter.” The producers of the experimental drugs are similarly shielded from possible consequences.
Georgia officials are ordered in the bill that state law shall take precedence over federal law on this particular issue and that they are required to defy certain FDA regulations. HB34 states that “no official, employee, or agent of the state shall block or attempt to block an eligible patient’s access to an investigational drug, biological product, or device.” Health care providers and government agencies are authorized to cover these experimental drugs and procedures under the bill as well.
HB34 is apart of a greater trend promoting medical freedom that is sweeping the nation. During this most recent November election, Arizona residents approved Prop. 303, known as the Arizona Terminal Patients’ Right to Try Referendum. The proposition allows investigational drugs, biological products or devices to be made available to eligible terminally ill patients, which are not permitted under the FDA. Prop. 303 is similar to laws passed in Colorado, Michigan, Missouri, and Louisiana, known as “Right to Try” laws.
These laws, though they deal with a small aspect of the FDA’s regulations, provides us with a clear model of how to nullify federal laws that violate the Constitution by narrowing the influence of nullification to limited aspects of the law itself.
The effectiveness of such nullification laws rests in the obvious logic behind them; dying people should not be deprived of their right to any means that might ease their pain or keep them alive, and it is extremely difficult for opponents to argue that dying people should be forced to use only drugs approved of by bureaucrats who are incapable of empathizing with their possible suffering.
In Louisiana, for example, the law received 80 percent approval, according to one survey. In three of the states that have passed “Right to Try” laws, not a single politician voted nay. In Michigan, the entire state House voted yea with no abstentions, while only two senators voted against it.
...
